4743.TWO

Oneness Biotech Co., Ltd. [4743.TWO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

4743.TWO Stock Summary

The Moving Average Convergence Divergence (MACD) for 4743.TWO recently turned positive (within last 10 days).

Top 10 Correlated ETFs

4743.TWO

Top 10 Correlated Stocks

4743.TWO

In the News

4743.TWO Financial details

Company Rating

Market Cap

78.01B

Income

-1.32B

Revenue

86.78M

Book val./share

Cash/share

Dividend

0.1

Dividend %

0.05%

Employees

180

Optionable

Shortable

Yes

Earnings

09 May 2024

P/E

-56.14

Forward P/E

PEG

1.23

P/S

1094.44

P/B

5.86

P/C

P/FCF

-94.36

Quick Ratio

56.54

Current Ratio

Debt / Equity

LT Debt / Equity

EPS (TTM)

-2.91

EPS next Y

EPS next Q

EPS this Y

-454.88%

EPS next Y

EPS next 5Y

EPS last 5Y

20.4%

Revenue last 5Y

45.14%

Revenue Q/Q

34.92%

EPS Q/Q

114%

SMA20

-14.08%

SMA50

-22.78%

SMA100

-41.9%

Inst Own

Inst Trans

ROA

-10%

ROE

-10%

ROC

-0.1%

Gross Margin

36%

Oper. Margin

-1930%

Profit Margin

-1952%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

161.0-253.5

52W High

-75.3%

52W Low

-61.18%

RSI

Rel Volume

0.95

Avg Volume

1.99M

Volume

1.89M

Perf Week

6.29%

Perf Month

-17.11%

Perf Quarter

-51.74%

Perf Half Y

-52.11%

Beta

1.525

Volatility

1.63%, 6.61%

Prev Close

-1.26%

Price

62.5

Change

-0.32%

4743.TWO Financial Performance

4743.TWO Dividend History

4743.TWO Frequently Asked Questions

What is Oneness Biotech Co., Ltd. stock symbol ?

Oneness Biotech Co., Ltd. is a TW stock and trading under the symbol 4743.TWO

What is Oneness Biotech Co., Ltd. stock quote today ?

Oneness Biotech Co., Ltd. stock price is $62.5 today.

Is Oneness Biotech Co., Ltd. stock public?

Yes, Oneness Biotech Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.99M
Market Capitalization 78.01B
Employee 180
CEO Ms. Chih-Hui Cheng
Headquarters Taipei,TW
IPO Date 2011-09-23
Website https://www.onenessbio.com.tw

Oneness Biotech Co., Ltd engages in the research and development of new drugs, and sale of pharmaceutical and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis and systemic sclerosis; FB825, which is in Phase II clinical trial for treating atopic dermatitis, allergic diseases, and asthma; and FB918, a human monoclonal antibody, which is in pre-clinical stage for the treatment of allergic asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and sale of agricultural products. The company was incorporated in 2008 and is headquartered in Taipei City, Taiwan.